10 employees
Increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market.
2012
$28K
from 1 investors over 1 rounds
PathDrugomics Inc. raised $28K on July 10, 2013
Investors: Alchemist Accelerator